Company facts
Early-stage
- Founded
- 2022
- Employees
- 10
- Headquarters
- United States
About
Engage Bio has developed Tethosomes, a new class of non-viral DNA which finally unleashes potent, durable, redosable, and scalable genetic medicine. In 2026 Engage was acquired by Eli Lilly.